SPRING BK PHARMACEUTICALS IN - COM (SBPH)

CUSIP: 849431101

Q4 2016 13F Holders as of 31 Dec 2016

Type / Class
Equity / COM
Total 13F shares
882,854
Share change
+881,633
Total reported value
$7,053,000
Price per share
$7.99
Number of holders
11
Value change
+$7,040,000
Number of buys
10
Number of sells
2

Quarterly Holders Quick Answers

What is CUSIP 849431101?
CUSIP 849431101 identifies SBPH - SPRING BK PHARMACEUTICALS IN - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPRING BK PHARMACEUTICALS IN - COM (SBPH) as of Q4 2016

As of 31 Dec 2016, SPRING BK PHARMACEUTICALS IN - COM (SBPH) was held by 11 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 882,854 shares. The largest 10 holders included BAKER BROS. ADVISORS LP, Alyeska Investment Group, L.P., PARSONS CAPITAL MANAGEMENT INC/RI, SUSQUEHANNA INTERNATIONAL GROUP, LLP, SILVERCREST ASSET MANAGEMENT GROUP LLC, DAFNA Capital Management LLC, BRYN MAWR TRUST Co, Verity & Verity, LLC, MORGAN STANLEY, and BESSEMER GROUP INC. This page lists 11 institutional shareholders reporting positions in this security for the Q4 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.